NervGen Pharma Corp.
NGEN.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.29% | -29.01% | 14.15% | -16.11% | -22.83% |
| Total Receivables | -75.98% | 138.98% | -60.77% | -18.84% | 7,320.83% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 78.32% | 72.19% | -0.53% | -53.37% | 64.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -63.41% | 27.26% | 52.71% | -61.18% | 15.76% |
| Total Current Assets | 83.04% | -24.84% | 12.91% | -18.98% | -18.65% |
|
|
|||||
| Total Current Assets | 83.04% | -24.84% | 12.91% | -18.98% | -18.65% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.78% | -5.21% | 2.14% | -2.88% | -8.86% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -76.42% |
| Total Assets | 80.30% | -24.34% | 12.61% | -18.63% | -18.53% |
|
|
|||||
| Total Accounts Payable | -28.32% | -2.79% | 7.09% | 15.52% | -93.15% |
| Total Accrued Expenses | -12.37% | 1.42% | 22.38% | -8.98% | 57.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -74.48% | -43.50% | -25.66% | -15.83% | -4.65% |
| Total Finance Division Other Current Liabilities | 44.68% | -17.54% | 34.20% | -16.74% | 14.12% |
| Total Other Current Liabilities | 44.68% | -17.54% | 34.20% | -16.74% | 14.12% |
| Total Current Liabilities | 25.14% | -12.09% | 30.13% | -14.42% | 19.79% |
|
|
|||||
| Total Current Liabilities | 25.14% | -12.09% | 30.13% | -14.42% | 19.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -76.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.14% | -12.09% | 30.13% | -14.46% | 19.55% |
|
|
|||||
| Common Stock & APIC | 15.64% | 0.20% | 13.07% | 1.60% | -5.30% |
| Retained Earnings | -24.40% | -1.86% | -14.43% | -3.48% | -3.02% |
| Treasury Stock & Other | 81.58% | 0.02% | 8.71% | 4.51% | 1.49% |
| Total Common Equity | 220.07% | -213.62% | -169.66% | -46.02% | -73.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 220.07% | -213.62% | -169.66% | -46.02% | -73.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 220.07% | -213.62% | -169.66% | -46.02% | -73.64% |
|
|
|||||